Serum FGF23 levels, which are elevated with the progression of CKD, are associated with left ventricular hypertrophy (LVH), a major contributor to cardiovascular disease (Jimbo and Shimosawa, 2014; Wyatt and Drüeke, 2016). This evidence concerns the gene FGF23 and left ventricular hypertrophy.